Literature DB >> 27650502

Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53.

Marcia A Ogasawara1, Jinyun Liu2, Helene Pelicano2, Naima Hammoudi1, Carlo M Croce3, Michael J Keating4, Peng Huang5.   

Abstract

Deletion of chromosome 17p with a loss of p53 is an unfavorable cytogenetic change in chronic lymphocytic leukemia (CLL) with poor clinical outcome. Since p53 affects mitochondrial function and integrity, we examined possible mitochondrial changes in CLL mice with TCL1-Tg/p53-/- and TCL1-Tg/p53+/+ genotypes and in primary leukemia cells from CLL patients with or without 17p-deletion. Although the expression of mitochondrial COX1, ND2, and ND6 decreased in p53-/-CLL cells, there was an increase in mitochondrial biogenesis as evidenced by higher mitochondrial mass and mtDNA copy number associated with an elevated expression of TFAM and PGC-1α. Surprisingly, the overall mitochondrial respiratory activity and maximum reserved capacity increased in p53-/- CLL cells. Our study suggests that leukemia cells lacking p53 seem able to maintain respiratory function by compensatory increase in mitochondrial biogenesis.
Copyright © 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Chronic lymphocytic leukemia; Mitochondrial biogenesis; p53

Mesh:

Substances:

Year:  2016        PMID: 27650502      PMCID: PMC5108679          DOI: 10.1016/j.mito.2016.09.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  28 in total

1.  Measurement of mitochondrial DNA copy number.

Authors:  Victor Venegas; Michelle C Halberg
Journal:  Methods Mol Biol       Date:  2012

2.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

Authors:  Min Wu; Andy Neilson; Amy L Swift; Rebecca Moran; James Tamagnine; Diane Parslow; Suzanne Armistead; Kristie Lemire; Jim Orrell; Jay Teich; Steve Chomicz; David A Ferrick
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-13       Impact factor: 4.249

3.  Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine.

Authors:  J S Carew; S T Nawrocki; R H Xu; K Dunner; D J McConkey; W G Wierda; M J Keating; P Huang
Journal:  Leukemia       Date:  2004-12       Impact factor: 11.528

4.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.

Authors:  Roberta Bichi; Susan A Shinton; Eric S Martin; Anatoliy Koval; George A Calin; Rossano Cesari; Giandomenico Russo; Richard R Hardy; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

5.  Molecular control of mitochondrial function in preimplantation mouse embryos.

Authors:  Jacob Thundathil; France Filion; Lawrence C Smith
Journal:  Mol Reprod Dev       Date:  2005-08       Impact factor: 2.609

Review 6.  Cytogenetics in CLL and related disorders.

Authors:  G Juliusson; G Gahrton
Journal:  Baillieres Clin Haematol       Date:  1993-12

7.  P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA.

Authors:  Yoichiro Yoshida; Hiroto Izumi; Takayuki Torigoe; Hiroshi Ishiguchi; Hideaki Itoh; Dongchon Kang; Kimitoshi Kohno
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

8.  Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells.

Authors:  J Liu; G Chen; L Feng; W Zhang; H Pelicano; F Wang; M A Ogasawara; W Lu; H M Amin; C M Croce; M J Keating; P Huang
Journal:  Leukemia       Date:  2013-04-23       Impact factor: 11.528

Review 9.  Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.

Authors:  Michael Hallek
Journal:  Am J Hematol       Date:  2013-09       Impact factor: 10.047

Review 10.  Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect.

Authors:  Renée F Johnson; Neil D Perkins
Journal:  Trends Biochem Sci       Date:  2012-05-23       Impact factor: 13.807

View more
  5 in total

Review 1.  PGC1α: Friend or Foe in Cancer?

Authors:  Francesca Mastropasqua; Giulia Girolimetti; Maria Shoshan
Journal:  Genes (Basel)       Date:  2018-01-22       Impact factor: 4.096

2.  Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes.

Authors:  Gabriela Galicia-Vázquez; Raquel Aloyz
Journal:  Front Oncol       Date:  2018-09-26       Impact factor: 6.244

3.  Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.

Authors:  Bahram Sharif-Askari; Daniel Doyon; Miltiadis Paliouras; Raquel Aloyz
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

4.  p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.

Authors:  Jiuling Li; Yany Li; Lanlan Chen; Bingbing Yu; Yanan Xue; Rui Guo; Jing Su; Yanan Liu; Liankun Sun
Journal:  Mol Med Rep       Date:  2020-05-05       Impact factor: 2.952

5.  Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line.

Authors:  Daiane G Franco; Isabele F Moretti; Suely K N Marie
Journal:  Molecules       Date:  2018-05-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.